Litecoin Reserve Company MEI Pharma Renamed Litecoin Strategy
2025-09-10 20:59:47
US-listed Litecoin reserve company MEI Pharma has announced the change of its name to Litecoin Strategy (Nasdaq: LITS).
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
莱特币储备公司MEI Pharma更名为Litecoin StrategyNext article：
高盛CEO所罗门：预计美联储9月会降息25个基点
